Search Results
Aug 27, 2026, 09:12 ET Faster Answers, Better Decisions: ADLM 2026 Highlights
SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026
More news about: QuidelOrtho Corporation
Aug 06, 2026, 16:05 ET QuidelOrtho Reports Second Quarter 2026 Financial Results
SAN DIEGO, Aug. 6, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended
More news about: QuidelOrtho Corporation
Jul 24, 2026, 07:00 ET QuidelOrtho to Report Second Quarter 2026 Financial Results
SAN DIEGO, July 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will report its financial results for the
More news about: QuidelOrtho Corporation
Jul 23, 2026, 09:21 ET Beyond Fentanyl: How the Drug Crisis Is Changing
SAN DIEGO, July 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 59 of its Science Bytes podcast examining how the drug overdose landscape continues
More news about: QuidelOrtho Corporation
Jul 15, 2026, 19:31 ET QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CorporationWith expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes
More news about: QuidelOrtho Corporation
Jun 23, 2026, 07:12 ET QuidelOrtho Appoints Micah Young as Chief Financial Officer
companiesSAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho" or the "Company"), a leading global provider of diagnostic solutions, today announced the appointment of Micah Young as Chief Financial
More news about: QuidelOrtho Corporation
Jun 02, 2026, 07:12 ET QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies
CorporationWith expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point
More news about: QuidelOrtho Corporation
May 21, 2026, 09:18 ET When Blood Compatibility Becomes a Pregnancy Risk
SAN DIEGO, May 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 58 of its Science Bytes podcast, focusing on hemolytic disease of the fetus and
More news about: QuidelOrtho Corporation
May 20, 2026, 07:00 ET QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
SAN DIEGO, May 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, announced today that members of its management team will participate
More news about: QuidelOrtho Corporation
May 05, 2026, 16:05 ET QuidelOrtho Reports First Quarter 2026 Financial Results
SAN DIEGO, May 5, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced financial results for the first quarter ended
More news about: QuidelOrtho Corporation
Apr 23, 2026, 09:32 ET Understanding and Addressing Syphilis Trends - and What's Being Missed
SAN DIEGO, April 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 57 of its Science Bytes podcast, focusing on evolving syphilis trends in the United
More news about: QuidelOrtho Corporation
Apr 20, 2026, 07:12 ET QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
–SAN DIEGO, April 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, announced today it has completed the acquisition of LEX Diagnostics
More news about: QuidelOrtho Corporation
Apr 15, 2026, 16:15 ET QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance
SAN DIEGO, April 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, today announced preliminary unaudited revenue for the first quarter of 2026,
More news about: QuidelOrtho Corporation
Mar 24, 2026, 07:00 ET Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment of Nathaniel "Nate" Sisitsky as its
More news about: QuidelOrtho Corporation
Feb 19, 2026, 09:17 ET Faster Cardiac Answers with High‑Sensitivity Troponin
SAN DIEGO, Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carlstrom, Global Medical
More news about: QuidelOrtho Corporation
Feb 18, 2026, 16:05 ET QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced that members of its management team will present
More news about: QuidelOrtho Corporation
Feb 16, 2026, 04:48 ET QuidelOrtho firma un acuerdo estratégico de suministro para ampliar su cartera mundial de inmunoensayos
más amplios y opciones de sistemas flexibles.Fuente: QuidelOrtho CorporationAcerca de QuidelOrthoQuidelOrtho (Nasdaq: QDEL) es líder mundial en soluciones diagnósticas, con experiencia en química clínica, inmunoensayos, inmunohematología y diagnóstico molecular. La empresa
More news about: QuidelOrtho Corporation
Feb 16, 2026, 03:42 ET QuidelOrtho firma un acuerdo de suministro estratégico para ampliar su cartera global de inmunoensayos
de productos y opciones de sistemas flexibles.Emisor: QuidelOrtho CorporationAcerca de QuidelOrthoQuidelOrtho (Nasdaq: QDEL) es líder mundial en soluciones de diagnóstico, con experiencia en química clínica, inmunoensayo, inmunohematología y diagnóstico molecular. La compañía
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
seeking broader menus and flexible system options.Source: QuidelOrtho CorporationAbout QuidelOrthoQuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho geht strategische Liefervereinbarung zur Erweiterung des globalen Immunoassay-Portfolios ein
Immunoassay-Lösungen bereitzustellen.Quelle: QuidelOrtho CorporationInformationen zu QuidelOrthoQuidelOrtho (Nasdaq: QDEL) ist ein weltweit führendes Unternehmen für diagnostische Lösungen mit Fachwissen in den Bereichen klinische Chemie, Immunoassays, Immunhämatologie sowie
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
seeking broader menus and flexible system options.Source: QuidelOrtho CorporationAbout QuidelOrthoQuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho conclut un accord d'approvisionnement stratégique pour élargir son portefeuille mondial d'immunoessais
larges et d'options de systèmes flexibles.Source : QuidelOrtho CorporationÀ propos de QuidelOrthoQuidelOrtho (Nasdaq : QDEL) est un leader mondial dans le domaine des solutions de diagnostic, avec une expertise en chimie clinique, en immunoessais, en immunohématologie et en
More news about: QuidelOrtho Corporation
Feb 11, 2026, 16:05 ET QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results
―SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced financial results for the fourth quarter and full-year
More news about: QuidelOrtho Corporation
Feb 03, 2026, 07:12 ET QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards
YearSAN DIEGO, Feb. 3, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") received the Excellence Services Label for its Customer and Technical Services in EMEA, awarded by the independent association Esprit
More news about: QuidelOrtho Corporation
Jan 22, 2026, 07:12 ET Strengthening the blood supply: Awareness, challenges and donor impact
SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released episode 55 of its Science Bytes podcast, featuring Michelle Mullens, Global Portfolio
More news about: QuidelOrtho Corporation